Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Non-randomized evaluation studies (TREND)].

Carles Vallvé1, Maite Artés, Erik Cobo

  • 1Farmacólogo clínico, Cardedeu, Barcelona, España. vallve@telefonica.net

Medicina Clinica
|February 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the burden of cognitive impairment associated with schizophrenia: Results from the international LUCIA study.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Publisher preferences for a journal transparency tool: A modified three-round Delphi study.

F1000Research·2025
Same author

Rejoinder to the 'Letter to the Editor' on "Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies".

The AAPS journal·2024
Same author

Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study.

European journal of dermatology : EJD·2024
Same author

Correction: Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies.

The AAPS journal·2024
Same author

Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies.

The AAPS journal·2024
Same journal

Effectiveness of cardiac Holter monitoring for more than four weeks for the detection of occult atrial fibrillation in embolic stroke of undetermined source.

Medicina clinica·2026
Same journal

Artificial intelligence in surgical training and education: a narrative review.

Medicina clinica·2026
Same journal

Treatment of phantom limb syndrome with ketamine.

Medicina clinica·2026
Same journal

Comment on "Ticagrelor versus clopidogrel in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis".

Medicina clinica·2026
Same journal

Limitations in the interpretation of thyroid function tests.

Medicina clinica·2026
Same journal

Cerebrotendinous xanthomatosis without neurological manifestations: An atypical form with normal cholestanol levels.

Medicina clinica·2026
See all related articles

Transparent reporting is crucial for nonrandomized intervention studies when randomized trials are not feasible. The TREND checklist ensures clear reporting of methods and quantifies allocation uncertainty for reliable evidence.

Area of Science:

  • Clinical research methodology
  • Epidemiology
  • Biostatistics

Context:

  • Randomized clinical trials (RCTs) are the gold standard but not always feasible.
  • Nonrandomized intervention studies are essential alternatives in many research scenarios.
  • Ensuring transparency and rigor in nonrandomized study reporting is critical for valid scientific conclusions.

Purpose:

  • To advocate for the use of the TREND (Transparent Reporting of Evaluations with Nonrandomized Designs) checklist.
  • To provide guidelines for transparent reporting of nonrandomized intervention studies.
  • To emphasize the need for methodological rigor comparable to RCTs in nonrandomized designs.

Summary:

  • Nonrandomized studies should adopt methodological tools typically used in RCTs.

Related Experiment Videos

  • The TREND checklist facilitates transparent reporting of evaluations with nonrandomized designs.
  • Uncertainty introduced by the allocation mechanism in nonrandomized studies must be explicitly reported and quantified.

    • Impact:

    • Enhances the credibility and interpretability of evidence from nonrandomized intervention studies.
    • Improves the quality of research reporting, facilitating evidence synthesis and meta-analysis.
    • Supports informed decision-making in clinical practice and health policy by providing reliable data from diverse study designs.